Home : DrugWatch : Sutent : Newsfeeds

Sutent - Newsfeeds

Drugs & Medications - AVASTIN IV: Before using this medication, tell your doctor or pharmacist of all prescription and nonprescription/herbal products you may use, especially of: sunitinib. This document does not contain all possible interactions. Therefore, before using this product ...
A case of adult metastatic Xp11 translocation renal cell carcinoma ...: Herein, we describe the first successful case of systemic treatment of metastatic Xp11 RCC with sunitinib, a currently accepted standard of care in metastatic RCC, and attempt to elucidate potential mechanisms behind sunitinib activity in this ...
Tolerance of sunitinib in dialyzed patients with metastatic renal cell ...: Department of Oncology, Tom Baker Cancer Center, Calgary, Alberta, Canada. The use of sunitinib in dialysis patients is poorly described but is of clinical importance. We report 2 cases of patients receiving sunitinib for metastatic renal cell ...
ZIOPHARM Presents Positive Palifosfamide Sarcoma Randomized Phase II ...: ... a member of ZIOPHARM’s Medical Advisory Board, whose experience includes having served as lead investigator in the clinical trials leading to the approval of Gleevec TM and Sutent TM to treat GIST, a form of soft tissue sarcoma. “These data ...
Agennix AG Shares Begin Trading on Frankfurt Stock Exchange: Therefore, Agennix is considering initiating a Phase 2b trial in combination with Sutent® (sunitinib) in patients with RCC. Data in the Phase 2 trial in severe sepsis is on target to be available at the end of the fourth quarter of 2009.
Phase II Study Of Sunitinib In Men With Advanced Prostate Cancer: UroToday.com - In the Annals of Oncology , Dr. Dror Michaelson and associates reported Phase II data on the efficacy and safety of the tyrosine kinase inhibitor sunitinib in patients with castration-resistant prostate cancer (CRPC). Sunitinib ...
Novartis delivers strong operational performance in the first half of ...: ... an oral inhibitor of the mTOR pathway, was launched in the US after regulatory approval was granted in March as the first therapy for patients with advanced renal cell carcinoma (kidney cancer) after failure of treatment with sunitinib ...

Clinical Trial At The Cancer Institute Of New Jersey Focuses On New ...: The Sunitinib Plus Extended Courses of Irradiated Allogeneic Lymphocytes for Patients with Renal Cell Carcinoma -- or SPECIAL -- trial is sponsored by the United States Food and Drug Administration, which also will monitor the study. It will look at ...
Biotech Industry Veteran K. Peter Hirth Joins Alios BioPharma Board of ...: This includes the drug Sutent®, now owned by Pfizer through its acquisition of Pharmacia. Previously, Dr. Hirth was a vice president in research with Boehringer Mannheim where, among other responsibilities, he successfully led the company's ...
Cancer Drugs May Treat Type 1 Diabetes: In experiments with mice, they found that Gleevec and a similar cancer drug, Sutent, could prevent the onset of type 1 diabetes. Type 1 diabetes is usually diagnosed in children and young adults, and is caused by the inability of the body to make ...
PHARMA'S MARKET VIDEO: PFE sold $847 million worth of Sutent last year, a 46 percent increase. In addition to this very rare form of pancreatic cancer, the company says it is also doing late-stage tests of Sutent on breast, lung, colorectal, liver and prostate cancers. ...
Comments about: Go away, Palin, and stay away: Oncologists from a major teaching hospital in New York City have prescribed Sutent -- a medication that costs about $4,000 a month and could extend his life expectancy. "Most of my objections are that some second rate guy on the staff of the ...
Postcode lottery of cancer treatment: It looked at the fate of 40 patients treated by the University Hospitals Birmingham Foundation Trust who received drugs Sutent and Nexavar for kidney failure with those who did not get funding for them. Those who had the medication lived for 22 months ...
Biotech Industry Veteran K. Peter Hirth Joins Alios BioPharma Board of ...: This includes the drug Sutent®, now owned by Pfizer through its acquisition of Pharmacia. Previously, Dr. Hirth was a vice president in research with Boehringer Mannheim where, among other responsibilities, he successfully led the company's ...

Looking for a Washington, DC Sutent attorney? Get in touch with one of our Washington, DC Sutent attorneys now.

Content provided by MSN. LegalView is not responsible for the accuracy of the information provided above.

Pages: Previous 1 2

Need A Sutent Attorney?

First Name Last Name Email Address State

Legal Issue

DrugWatch: Sutent Click to select a Legal Issue

Has Your Health Been Negatively Affected?

Please Describe the Injury

close this window

Sutent Information

Click to View Our Legal Resources

Looking for a Washington, DC Sutent attorney? Get in touch with one of our Washington, DC Sutent attorneys now.

LegalView.info is sponsored by law firms with offices in many states. This website contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Your access to this site does not constitute a legal attorney-client relationship. The choice of a lawyer is an important decision and should not be based solely upon advertisements. To access important information concerning the sponsors and their commitment to the ethical practice of law, click here.

The participating law firms are as follows: Anapol Schwartz (Philadelphia, Pennsylvania; Cherry Hill, New Jersey; Media, Pennsylvania; Reading, Pennsylvania; Wheeling, WV). Cohen, Placitella & Roth (Red Bank, New Jersey; Philadelphia, Pennsylvania). J. F. Humphreys (Charleston, West Virginia). Lopez McHugh (Newport Beach, California; Philadelphia, PA; and Moorestown, NJ). Click here for more information about these law firms.

Some of our partner firms do not accept some types of cases. For details on these case exceptions, click here.

20120517-032012

Close (x)

Looking for an Attorney?

Please type your question:

First Name:
Last Name:
E-mail:
Phone Number *
() -

State * Legal Issue *

DrugWatch: Sutent Click to select a Legal Issue

Close (x)

Find Legal Help for Your Sutent Case - Submit Your Information Below

Do you need legal assistance with your Sutent case?
LegalView may be able to help.

Submit your information below for a free, no-cost evaluation.

We'll submit your information to one of our partner firms.
LegalView's partners represent clients throughout the United States, for a very wide range of legal issues. Submit your information now, to see if one of LegalView's partners can help!

* Indicates Required Fields

First name *

Last name *

Email Address *

Phone Number *
() -

State *

Legal Issue * DrugWatch: Sutent Change

Was There an Injury?

Please Describe The Injury

Please State Your Question *

DISCLAIMER and STATEMENT OF NON-CONFIDENTIALITY

By submitting this form, you agree that completing the above is not intended to create an attorney-client relationship.

Disclosure

Legal WebTV Network LLC, LegalView.com, and LegalWebMedia.com are group advertising sponsored by the attorneys identified here. It is not a lawyer referral service. If you submit information on this website, LegalWebMedia.com will submit your information to the law firms that pay for this group advertising and to respond to your requests for information concerning legal services in their assigned local areas. If there is no sponsoring firm in your state, your inquiry will be submitted to one of the sponsoring law firms on a predetermined, rotating basis. If the sponsoring law firm accepts your case, it will associate with licensed attorneys practicing in your state, if required; the sponsoring law firm may also contact other law firms to see if they may be able to assist.

The information provided by the LegalView.com and LegalWebMedia.com websites is for advertising and informational purposes and should not be considered as legal advice from the sponsoring attorneys. The websites contain general information and may not reflect current legal developments, verdicts, or settlements. LegalView.com contains information created by others or supplied through open forums; the sponsoring law firms are not responsible for the accuracy of this information. Any person viewing or receiving information from these websites should not act or refrain from acting on the basis of any such information without first seeking appropriate legal advice from an attorney in your area. Legal WebTV Network, LLC expressly disclaims any liability with respect to actions taken or not taken by the recipient based on any or all of the information or contents contained in these websites.

Any information sent to Legal WebTV Network LLC through this website is done using standard Web encryption techology. LegalView.com will exercise all reasonable care, within technological limits, to protect the confidentiality of any information submitted via Internet e-mail or through this website. By accessing this website, you may be seeking an attorney to represent you or legal advice. However, none of the sponsoring attorneys represent you yet.

The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Any transmission of information, whether via Internet e-mail or through the website, is solely for evaluation purposes by the sponsoring law firms and their associates. The transmission of any information to any attorney sponsoring advertising on LegalView.com or LegalWebMedia.com does not create an attorney-client relationship between the sender and any recipient. An attorney-client relationship can only be created by a written, signed-fee agreement entered into with an attorney. The sponsoring attorneys will treat your information as a confidential communication for the purpose of obtaining legal services or legal advice.

For more information about the sponsoring law firms, please click here.

This form is secure and encrypted. More information about secure forms and your privacy here.